Company attributes
Industry
CEO
Founder
Pitchbook URL
Date Incorporated
2013
Email Address
bd@tiltbio.com0
Full Address
Tukholmankatu 8 B,
Biomedicum 2B, (2nd floor)
00290 Helsinki, Finland.0
Investors
Founded Date
2013
Total Funding Amount (USD)
22,000,000
Latest Funding Round Date
February 7, 2023
Latest Funding Type
Patents Assigned (Count)
2
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
11,000,000
TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer that is headquartered in Helsinki, Finland and was founded in 2013 by Akseli Hemminki.
Timeline
No Timeline data yet.
